Advancing access to digitally enabled care for people living with diabetes

Posted on 15.06.2023

The MedTech Europe Diabetes Group continues its work of advancing digitally enabled care for the benefit of people living with Type 1 (T1) and Type 2 (T2) diabetes, their care teams, and wider health systems in Europe.

The Group is currently developing an ‘access framework’ for T2 diabetes care – in collaboration with national associations and key partners – to shed light on the main drivers and barriers impacting access to digitally enabled medical technologies for people living with T2 diabetes amongst selected EU member states. Digitally enabled diabetes care facilitates self-management, strengthens interactions with care teams, and improves outcomes and quality of life for people with both T1 and T2 diabetes – yet barriers to access remain.

For more information on the work of the MedTech Europe Diabetes Group on Type 2 diabetes, including this recent infographic on the role of medical technology, please visit the dedicated page on the website or get in touch with Tanja Valentin, Senior Adviser Diabetes.